NSETrading Window29 Jun 2026 · 29 Jun 2026, 11:41 am
Trading Window
CORONA Remedies Limited · CORONA
✦ AI SummaryRegulatory
CORONA Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from July 01, 2026, until 48 hours from the declaration of the unaudited financial results for the first quarter and three months ending on June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
CORONA Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
CORONAREMEDIES_29062026114044_Intimation_for_closure_of_Trading_Window.pdf
View document text
June 29, 2026
To, To,
Listing Operation Department Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla
Dalal Street, Mumbai – 400001 Complex, Bandra (E), Mumbai- 400051
(Scrip Code: 544644) (SYMBOL: CORONA)
Dear Sir / Madam,
Sub.: Intimation of Closure of Trading Window for dealing in securities of CORONA Remedies
Limited (Company) in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015
This is to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of
Insider Trading) Regulations, 2015, as amended and the Code of Conduct for Regulating,
Monitoring and Reporting of Insider Trading in the Securities of the Company, the Trading
Window for dealing in the securities of the Company shall remain closed with effect from
July 01, 2026 until 48 hours from the declaration of the unaudited financial results of the
Company for the first quarter and three months ending on June 30, 2026.
The date of Board Meeting, inter alia, to consider the unaudited financial results for the first
quarter and three months ending on June 30, 2026 will be intimated separately in due course.
You are requested to take note of the above.
Thanking you.
Yours faithfully,
For CORONA Remedies Limited
Chetna Dharajiya
Company Secretary and Compliance Officer